Therma Bright & CloudMD: 2 Trending TSXV Healthcare Stocks

Follow us on Google News:
 Therma Bright & CloudMD: 2 Trending TSXV Healthcare Stocks

Summary

  • CloudMD’s shares climbed by 9 per cent as the company announced to buy Rxi’s pharma logistic services.
  • Stocks of CloudMD have gained over 342 per cent in the last six months.
  • Therma Bright’s one-year return has skyrocketed by 3966 per cent, guided by its rapid COVID-19 test kit.

 


Canadian healthcare company CloudMD Software & Services Inc. (TSXV: DOC) is all set to acquire Rxi’s pharma logistic services that includes drug supply and patient navigation support wings. The stocks surged by nearly 9 per cent on Tuesday, boosted by the development.

Therma Bright Inc (TSXV: THRM), a medical device producer, announced on January 25 that it will retain all revenue and profits from the sale of its saliva-based rapid COVID-19 test. The shares popped up as much as 47 per cent on Tuesday. Now, the company holds all rights for its antigen rapid test’s research and development (R&D), production, retail, and regulatory.

Let us glance at these two Toronto Stock Exchange Venture (TSXV)-listed healthcare stocks’ performances:

 

CloudMD Software & Services Inc. (TSXV: DOC)

 

The telemedicine stock is up over 342 per cent in the last six months, boosted by the online drug orders. CloudMD holds a current market cap of C$ 456.5 million, with a price-to-book ratio of 9.643.

On January 22, the company completed its acquisition of Canadian Medical Directory, a directory of medical professionals, to add weight to its software-as-a-service (SaaS)-based telehealth data. With its impending acquisition of Rxi, the telehealth firm expects to improve its healthcare logistic services across the country.

CloudMD scrips have been trading actively for the last 50 days, with an average trading volume of 1.9 million. The stocks have risen 17 per cent in January 2021.

The company posted record revenue of $3.4 million n the third quarter of 2020 (ended on September 30), a sharp of 55 per cent a year ago. Its revenue from clinic services and pharmacies was C$ 2.9 million, a surge of 62 per cent from C$ 1.8 million in Q3 2019.

Therma Bright Inc. (TSXV: THRM)

 

Nearly 23.68 million shares of this medtech company were traded yesterday. Its one-year return has skyrocketed by 3966 per cent.

Therma Bright CEO Rob Fia stated that its rapid test’s 100 per cent acquisition of the sales and profits is a big win for its shareholders. He also said that the company has received considerable interest from health facilities in the UK, the US, and Canada.

The stock soared over 171 per cent year-to-date (YTD), driven by the developments around its rapid COVID-19 antigen test.

Therma Bright’s share has a price-to-earnings ratio of 87.65 and price-to-cashflow ratio of 1002.10. Its total listed shares outstanding are nearly 198.9 million.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK